Fundraising Fox

Dr. David Urech

Investor

Venture Partner at BioMedPartners

Basel, Basel, Switzerland

Find your path to Dr. David Urech

28 people in our graph share verified history with Dr. David Urech — schools, employers, funds. One of them is your warm intro.

Stefan FäsunlockedDr. David Urech: together at BioMedPartners
×11Dr. David Urech: together at BioMedPartners

About

A biotech entrepreneur and antibody engineer best known as co-founder and former CEO of Numab Therapeutics, which he built into a clinical-stage leader in multi-specific antibody therapeutics. He also co-founded Yellow Jersey Therapeutics whose lead asset was acquired by Johnson & Johnson in 2024 for approximately $1.25 billion.

Experience

  1. fourapesCommunity Foundation managercurrent2023 — presentDelaware, United States
  2. --Program manager at untitled companycurrent2019 — present

Skills & more

GoKubernetesSocial Media MarketingRuby on RailsRustPython (Programming Language)SQLC++C#JavaC (Programming Language)JavaScript
+7 morePostgreSQLSAP ProductsOracle DatabaseMySQLXcodeSwift (Programming Language).NET Framework

From Dr.'s professional profile.

Colleagues at BioMedPartners

Frequently asked questions

Who is Dr. David Urech?
A biotech entrepreneur and antibody engineer best known as co-founder and former CEO of Numab Therapeutics, which he built into a clinical-stage leader in multi-specific antibody therapeutics. He also co-founded Yellow Jersey Therapeutics whose lead asset was acquired by Johnson & Johnson in 2024 for approximately $1.25 billion.
Where does Dr. David Urech work?
Dr. David Urech is Venture Partner at BioMedPartners.
Where did Dr. David Urech go to school?
Dr. David Urech studied at University of St.Gallen (Bachelor's degree, Administration).

Same school